Yi‐Tzu Lee
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.5%
- Vibrio bacteria research studies
- Infections and bacterial resistance
Papers in
-
- Antibiotic Resistance in Bacteria 63
- Epidemiology 36
- Pneumonia and Respiratory Infections 15
- Urinary Tract Infections Management 10
- Co-authors
- Te-Li Chen (56 shared papers)Shu‐Chen Kuo (51 shared papers)Chang‐Phone Fung (31 shared papers)Chien-Pei Chen (11 shared papers)L. Kristopher Siu (8 shared papers)Wen-Long Cho (9 shared papers)Ya‐Sung Yang (29 shared papers)Yung-Chih Wang (27 shared papers)
- Journals
- Journal of Microbiology Immunology and Infection (20 papers)Antimicrobial Agents and Chemotherapy (11 papers)Frontiers in Microbiology (3 papers)International Journal of Antimicrobial Agents (3 papers)BMC Infectious Diseases (3 papers)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Yi‐Tzu Lee
87 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 110
- Molecular Medicine 1.3k
- Endocrinology 617
- Applied Microbiology and Biotechnology 186
- Pharmacology 337
- Microbiology 123
Countries citing papers authored by Yi‐Tzu Lee
This map shows the geographic impact of Yi‐Tzu Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Tzu Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Tzu Lee more than expected).
Fields of papers citing papers by Yi‐Tzu Lee
This network shows the impact of papers produced by Yi‐Tzu Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Tzu Lee. The network helps show where Yi‐Tzu Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi‐Tzu Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 105 | |
| 2 | 2013 | 76 | |
| 3 | 2012 | 76 | |
| 4 | 2011 | 75 | |
| 5 | 2014 | 56 | |
| 6 | 2015 | 54 | |
| 7 | 2009 | 53 | |
| 8 | 2009 | 46 | |
| 9 | 2018 | 45 | |
| 10 | 2008 | 44 | |
| 11 | 2010 | 44 | |
| 12 | 2014 | 43 | |
| 13 | 2015 | 42 | |
| 14 | 2017 | 38 | |
| 15 | 2012 | 37 | |
| 16 | 2017 | 36 | |
| 17 | 2011 | 34 | |
| 18 | Clinical characteristics of patients with Acinetobacter junii infection. | 2009 | 34 |
| 19 | 2020 | 33 | |
| 20 | 2014 | 33 |
About Yi‐Tzu Lee
Yi‐Tzu Lee is a scholar working on Molecular Medicine, Epidemiology, Endocrinology, Pharmacology and Molecular Biology, having authored 92 papers that have together received 1.8k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (63 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers), Vibrio bacteria research studies (19 papers), Pneumonia and Respiratory Infections (15 papers), Bacterial biofilms and quorum sensing (11 papers), Pharmaceutical and Antibiotic Environmental Impacts (11 papers), Urinary Tract Infections Management (10 papers) and Antibiotic Use and Resistance (6 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Endocrinology (617 citations), Applied Microbiology and Biotechnology (186 citations), Pharmacology (337 citations) and Microbiology (123 citations). Yi‐Tzu Lee has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Te-Li Chen, Shu‐Chen Kuo, Chang‐Phone Fung, Chien-Pei Chen, L. Kristopher Siu, Wen-Long Cho, Ya‐Sung Yang, Yung-Chih Wang, Feng‐Yee Chang and Fu‐Der Wang. Their work appears in journals such as Journal of Microbiology Immunology and Infection, Antimicrobial Agents and Chemotherapy, Frontiers in Microbiology, International Journal of Antimicrobial Agents and BMC Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.